LBO — SOUTHERN OCEAN MEDICAL CENTER
IRR: 17.1% | MOIC: 2.20x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.1%
IRR
2.20x
MOIC
$253.0M
Entry EV
$388.3M
Exit EV
$130.2M
Equity Invested
Sources & Uses
S&UTotal · $253.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $98.3M | 38.8% | |
| Sub Debt | $24.6M | 9.7% | |
| Equity | $130.2M | 51.5% | |
| Enterprise Value | $245.7M | 97.1% | |
| Transaction Fees | $7.4M | 2.9% | |
| Total Uses | $253.0M | 100.0% |
Interpretation
INTAt 2.20x MOIC and 17.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $37.0M |
| Exit Ev | $388.3M |
| Net Debt At Exit | $101.9M |
| Equity At Exit | $286.4M |
| Equity Invested | $130.2M |
| Total Value Created | $156.2M |
| Value From Growth | $130.3M |
| Value From Multiple | $12.3M |
| Value From Deleveraging | $21.0M |